Drawing for ESSENTIAL

USPTO serial 78847863

ESSENTIAL

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
ESTRADA, LINDA M
Law office
TMEG LAW OFFICE 104 - EXAMINING ATTORNEY ASSIGNED

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with ESSENTIAL?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Sandra B. Weiss

SANDRA B WEISS JONES DAY77 W WACKER STE 3500CHICAGO, IL 60601-1692UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
035Providing general business administration and management services on behalf of entities providing public or private clinical trials, medical studies or market research studies of pharmaceutical, pharmacogenomic, biotechnical, nutritional or medical products or devices in terms of evaluating third party clinical research sites for their ability to provide contractual research trade services; arranging of contractual trade services with selected third parties to perform such trials and studies; arranging of contractual trade services with third parties to collect and test laboratory specimens from clinical trial and study sites; and advertising and business management consultancy regarding clinical trials and studies and the recruitment of patients and consumers for such trials and studiesACTIVE—
041Educational services in the nature of providing courses, training, testing and workshops in the field of clinical research, product lifecycle management, medical education, and distributing course materials in connection therewith; training clinical trial site and study site personnel in the use of tests and rating systems for protocol requirements; training clinical trial site personnel in the use of medical and research equipment required by trial and study protocols; and educational services in the nature of arranging for conference and seminar speakers through a speakers' bureauACTIVE—
042Product development and contract research services relating to public or private clinical trials or medical studies of pharmaceutical, pharmacogenomic, nutritional, biotechnical or medical products or devices; laboratory research testing in the fields of pharmacology, nutrition, biotechnology and medicine; conducting medical, scientific and data analysis research services for clinical trials or studies; development or clinical trial methodologies, protocol and project design, data retrieval methods, clinical data management and preparing statistical reports resulting from such clinical trials or studies; advisory services in the field of product development and research provided to physicians involved in the planning and preparation of lifecycle management activities for pharmaceutical, pharmacogenomic, biotechnical, nutritional, or medical products or devices; and technical consulting services in the nature of preparing and filing documents to comply with U;S; Food and Drug Administration requirements concerning clinical trialsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB2): The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.

DateCodeEventWhat it means
Nov 8, 2007MAB2ABANDONMENT NOTICE MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Nov 7, 2007ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Apr 11, 2007GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Apr 11, 2007CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Mar 20, 2007ACECAMENDMENT FROM APPLICANT ENTERED—
Mar 20, 2007CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 20, 2007ALIEASSIGNED TO LIE—
Feb 12, 2007MAILPAPER RECEIVED—
Sep 18, 2006GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 18, 2006CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 10, 2006DOCKASSIGNED TO EXAMINER—
Jul 10, 2006AMPXPRELIMINARY/VOLUNTARY AMENDMENT - ENTERED—
Jul 10, 2006PARITEAS VOLUNTARY AMENDMENT RECEIVED—
Apr 1, 2006MDSCNOTICE OF DESIGN SEARCH CODE MAILED—
Mar 31, 2006NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance